Innoviva, Inc. (INVA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$21.33-0.09%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · INVA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenues | 440.0 | 411.3 | 358.7 | 310.5 | 331.3 | 391.9 | 336.8 | 261.0 | 261.0 | 217.2 | 133.6 | 53.9 |
| Total Revenues | 30.2 | 21.1 | 19.1 | 15.8 | 6.4 | 1.8 | 1.5 | — | — | 217.2 | 133.6 | 53.9 |
| Gross Profit | — | 307.7 | — | — | — | — | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||
| Selling, General & Admin | 126.4 | 113.3 | 115.7 | 98.2 | 63.5 | 16.2 | 13.9 | — | — | — | — | — |
| R&D Expenses | 28.7 | 30.6 | 13.7 | 33.9 | 41.4 | 0.6 | 1.8 | 0.0 | 0.0 | 1.4 | 1.4 | 2.6 |
| Operating Income | 162.6 | 163.7 | — | 113.9 | 286.9 | 375.1 | 321.1 | 246.4 | 238.3 | 183.6 | 109.0 | 31.6 |
| Earnings from Continuing Operations | ||||||||||||
| Interest Expense | 18.2 | 16.7 | 22.2 | 19.2 | 15.8 | 19.1 | 18.3 | 18.7 | 24.0 | 43.6 | 52.4 | 51.8 |
| EBT, Incl. Unusual Items | 419.4 | 326.9 | 37.4 | 194.1 | 286.9 | 445.3 | 354.2 | 232.9 | 210.3 | — | 59.6 | (18.8) |
| Income Tax Expense | 62.2 | 55.7 | 14.0 | 14.4 | 66.7 | 76.4 | 60.4 | 41.9 | (196.1) | 0.0 | — | 0.0 |
| Net Income | ||||||||||||
| Minority Interest | — | — | — | 0.0 | 6.3 | 103.0 | 69.4 | 33.7 | 11.3 | 0.1 | — | — |
| Net Income | 357.2 | 271.2 | 23.4 | 179.7 | 220.3 | 368.8 | 293.8 | 191.0 | 406.3 | 134.3 | 59.5 | (18.8) |
| Per Share | ||||||||||||
| Basic EPS | 4.87 | 4.02 | 0.37 | 2.75 | 3.07 | 3.24 | 2.21 | 1.55 | 3.92 | 1.25 | 0.54 | — |
| Diluted EPS | 4.87 | 3.30 | 0.36 | 2.20 | 2.37 | 2.87 | 2.02 | 1.43 | 3.53 | 1.17 | 0.53 | — |
| Revenue per Share | 0.41 | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | — | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.75 |
| Basic Weighted Avg Shares | 73.4 | 67.4 | 62.7 | 65.4 | 69.6 | 82.1 | 101.3 | 101.2 | 100.8 | 106.9 | 110.3 | — |
| Diluted Weighted Avg Shares | 73.4 | 84.8 | 74.2 | 86.9 | 95.2 | 94.3 | 113.6 | 113.4 | 113.4 | 119.9 | 123.2 | — |
| Supplemental | ||||||||||||
| EBITDA | — | — | — | — | — | 388.9 | 335.0 | 260.2 | 252.1 | 197.6 | 122.9 | 45.5 |
| EBIT | 162.6 | 163.7 | — | 113.9 | 286.9 | 375.1 | 321.1 | 246.4 | 238.3 | 183.6 | 109.0 | 31.6 |
| Effective Tax Rate | 14.8% | — | — | 7.4% | 23.2% | 17.2% | 17.1% | 18.0% | -93.3% | — | — | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.